(Q36385251)

13 August 2017

1 reference

title

Positron emission tomography as a research tool in the investigation of psychiatric and psychological disorders (English)

1 reference

positron emission tomography

13 August 2017

1 reference

2

1 reference

13 August 2017

3

1 reference

13 August 2017

Jones AK

1

1 reference

13 August 2017

1 March 1991

1 reference

Bailliere's clinical endocrinology and metabolism

13 August 2017

17

0 references

published in

1 reference

13 August 2017

5

1 reference

13 August 2017

1

1 reference

13 August 2017

187-203

1 reference

Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Reduction of prefrontal cortex glucose metabolism common to three types of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Patterns of metabolic activity in the treatment of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Effects of acute and chronic neuroleptic treatment on the activity of midbrain dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Sleep pattern alterations by naloxone. Partial prevention by haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Dysfunction in a prefrontal substrate of sustained attention in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Positron emission tomography in schizophrenic patients with and without neuroleptic medication.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission Tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

The relationship between global and local changes in PET scans.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Reversibility of hemodynamic hypofrontality in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Regional Brain Function in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Distribution of cerebral activity in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

New labelled ligand for in-vivo studies of opioid physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Regional cerebral opioid receptor studies with [11C]diprenorphine in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Dopaminergic mechanisms and cognitive deficit in schizophrenia. A neurobiological model

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Morphine effects on human REM state, waking state and NREM sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Three subtypes of chronic schizophrenia identified using 11C-glucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Combination of dynamic and integral methods for generating reproducible functional CBF images.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Heroin and human sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

The distribution of alterations in energy metabolism in the rat brain produced by apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

The opiate antagonist naloxone does not arouse man from natural delta sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Eeg-behavioral dissociation after morphine- and cyclazocine-like drugs in the dog: further evidence for two opiate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

A focal brain abnormality in panic disorder, a severe form of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

In vivo autoradiography: Visualization of stress-induced changes in opiate receptor occupancy in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980103-X

7 January 2021

10.1016/S0950-351X(05)80103-X

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

1645517